CompletedNCT02556060
Lamotrigine for Ketamine Dependence
About this title
Read the official source — NCT02556060Medication studyAges 18–65TaiwanAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- TaipeiSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateSeptember 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Taipei City Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Taiwan
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02556060
- Official title
Show the full official title
Lamotrigine for Ketamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Taipei
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Taipei City Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including lamotrigine and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
